EOS imaging is set to launch EOSedge, the company’s new generation imaging system, across Europe, Canada and Australia, having secured regulatory approvals in the respective regions.

The French medical device company plans to unveil the new imaging system at the Radiological Society of North America (RSNA) 2019 Annual Meeting, which begins on 1 December 2019.

According to EOS imaging, EOSedge features the latest technological innovations in X-ray detection, high image resolution, and low-dose radiation to generate musculoskeletal imaging exams.

EOSedge can control radiation dose along the patient’s body

The imaging system uses the new Flex Dose technology to control radiation dose along the patient’s body and also for high-resolution photon counting detection to deliver optimal image quality for musculoskeletal radiography.

EOS imaging revealed that the open cabin of the EOSedge imaging system comes with a motorized, enlarged patient platform. This is said to facilitate easy access to a wider range of patients, and help in faster patient positioning apart from providing larger fields of examination.

The new imaging system offers local and full body, weight-bearing, low-dose biplanar exams of adult and pediatric patients, thereby delivering unbiased images and precise anatomical data of patients in functional positions, said EOS imaging.

EOSedge alongside the first-generation EOS system is said to be designed to seamlessly work with EOS Advanced Orthopedic Solutions that including 3DServices, EOSapps 3D surgical planning and EOSlink.

EOS imaging CEO Mike Lobinsky said: “We engineered EOSedge to equip both radiologists and orthopedic surgeons with a best-in-class imaging system that combines the latest innovations to provide high quality diagnostic capabilities of orthopedic conditions at a low dose.

“Images and data obtained with EOSedge will further fuel our Advanced Orthopedic Solutions, while addressing a broad range of imaging and orthopedic surgery challenges.”

The new imaging system has been granted the CE Mark in Europe, approved by Health Canada and Australia. EOS imaging has a pending 510(k) review with the US Food and Drug Administration (FDA) for seeking approval for the imaging system.